Menu

-Omics Analysis for Brain Disorders

The Scientist is bringing together a panel of experts to present their work and provide insight into the use of -omics in investigating neurological disorders.

Oct 29, 2018
The Scientist Creative Services Team

FREE Webinar

Wednesday, February 27, 2019
2:30-4:00 PM Eastern Time
Register Now

Progress towards the development of effective therapies for brain disorders is held back by a lack of understanding of pathological mechanisms. However, our understanding has been vastly improved by recent advances in systems biology: genomics, epigenomics, transcriptomics, proteomics, and metabolomics. Advances in metabolomics for example has demonstrated the complexity of Alzheimer’s Disease (AD) and other neurodegenerative conditions, as well as underscored the challenges in developing efficacious therapies. By defining systems-level mechanisms in neurodegenerative disease, insights into disease mechanisms can be garnered, biomarker panels can be advanced, and individualized medicine can be developed. The Scientist is bringing together a panel of experts to present their work and provide insight into the use of -omics in investigating neurological disorders.

Topics to be covered:

  • Integrative proteomics for novel target and biomarker discovery in Alzheimer’s Disease
  • The application of metabolomics for biomarker discovery in Alzheimer's Disease
  • Using quantitative proteomics to identify converging molecular mechanisms underlying autism

Register Now

Meet the Speakers:

Nicholas Seyfried, PhD
Associate Professor, Depts. of Biochemistry & Neurology
Emory School of Medicine

Eugenia Trushina, PhD
Associate Professor, Depts. of Neurology & Pharmacology,
Director, Mitochondrial Neurobiology & Therapeutics Laboratory
Mayo Clinic

Bryen A. Jordan, PhD
Associate Professor, Dominick P. Purpura Department of Neurosciences
Albert Einstein College of Medicine

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening